Similar Papers

Paper Title
Journal
Date
Author
Adjuvant chemotherapy for surgically resected non–small cell lung cancer
Stephanie Heon ... Bruce E Johnson
The Journal of Thoracic and Cardiovascular Surgery | VOL. 144
Stephanie Heon, et. al.Stephanie Heon ... Bruce E Johnson
12 Apr 2012
Role of adjuvant radiation therapy for squamous cell carcinoma (SCC) of the vulva and single lymph node metastasis (159)
Dimitrios Nasioudis ... Erin George
Gynecologic Oncology | VOL. 166
Dimitrios Nasioudis, et. al.Dimitrios Nasioudis ... Erin George
01 Aug 2022
Impact of adjuvant chemotherapy on the overall survival of patients with advanced stage low-grade serous ovarian carcinoma (130)
Dimitrios Nasioudis ... Fiona Simpkins
Gynecologic Oncology | VOL. 166
Dimitrios Nasioudis, et. al.Dimitrios Nasioudis ... Fiona Simpkins
01 Aug 2022
Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
Leigh Casadaban ... Ajay V Maker
Cancer | VOL. 122
Leigh Casadaban, et. al.Leigh Casadaban ... Ajay V Maker
15 Jul 2016
View more papers

More From: Gynecologic Oncology

Paper Title
Journal
Date
Author
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258.
Aine Clements ... Angeles Alvarez Secord
Gynecologic oncology | VOL. 193
Aine Clements, et. al.Aine Clements ... Angeles Alvarez Secord
23 Jan 2025
Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results.
David M O'Malley ... Michele Maio
Gynecologic oncology | VOL. 193
David M O'Malley, et. al.David M O'Malley ... Michele Maio
22 Jan 2025
Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcoma.
Michael D Toboni ... Nathaniel Jones
Gynecologic oncology | VOL. 193
Michael D Toboni, et. al.Michael D Toboni ... Nathaniel Jones
20 Jan 2025
Cost-effectiveness of an additional hysterectomy after initially conservative treatment for cervical adenocarcinoma in situ.
M Schaafsma ... N.E Van Trommel
Gynecologic oncology | VOL. 193
M Schaafsma, et. al.M Schaafsma ... N.E Van Trommel
17 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.